Schedule 13G ownership disclosure
Cascadian Therapeutics Inc
Security class unavailable · CUSIP: 14740B606
Event date: 2018-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-18-017853
- Form type
- SC 13G
- Filer
- BAUPOST GROUP LLC/MA
- CIK
- CIK 1061768
- Filed
- Apr 09, 2018
- Reporting period
- Mar 31, 2018
- Description
- Schedule 13G beneficial ownership